MDG1.DE实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 23:36):

Stats
今日成交量	44 837.00
平均成交量	30 393.00
市值	44.36M
EPS	€0 ( 2024-04-25 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-2.39
ATR14	€0.0330 (2.17%)

音量相关性

長: -0.06 (neutral)

短: -0.25 (neutral)

Signal:(47.641) Neutral

Medigene AG 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Medigene AG 相关性 - 货币/商品

0.60
( weak )

0.62
( weak )

0.00
( neutral )

0.57
( weak )

-0.63
( weak negative )

-0.61
( weak negative )

Medigene AG 财务报表

Annual	2023
营收:	€6.03M
毛利润:	€2.98M (49.40 %)
EPS:	€-0.660

FY	2023
营收:	€6.03M
毛利润:	€2.98M (49.40 %)
EPS:	€-0.660

FY	2023
营收:	€0
毛利润:	€0 (0.00 %)
EPS:	€0

FY	2022
营收:	€31.25M
毛利润:	€29.26M (93.65 %)
EPS:	€-0.340

Financial Reports:

No articles found.

Medigene AG

Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company is developing personalized T cell-based therapies with a focus on T cell receptor-modified T cells in the areas of unmet medical needs, which are in clinical development. It also focuses on dendritic cell vaccines and T cell-specific monoclonal antibodies. In addition, the company focuses on developing and marketing RhuDex for hepatology and gastroenterology indications. Medigene AG has a strategic partnership with 2seventy bio, Inc. for the development of T cell receptors. The company also has research collaboration agreements on novel cancer antigens for immunotherapies with the Université de Montréal; and with Cytovant Sciences Co. Ltd. It has operations in Europe, the United States, Asia, and internationally. The company was founded in 1994 and is headquartered in Munich, Germany.